These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25961942)

  • 1. PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
    Maass PG; Aydin A; Luft FC; Schächterle C; Weise A; Stricker S; Lindschau C; Vaegler M; Qadri F; Toka HR; Schulz H; Krawitz PM; Parkhomchuk D; Hecht J; Hollfinger I; Wefeld-Neuenfeld Y; Bartels-Klein E; Mühl A; Kann M; Schuster H; Chitayat D; Bialer MG; Wienker TF; Ott J; Rittscher K; Liehr T; Jordan J; Plessis G; Tank J; Mai K; Naraghi R; Hodge R; Hopp M; Hattenbach LO; Busjahn A; Rauch A; Vandeput F; Gong M; Rüschendorf F; Hübner N; Haller H; Mundlos S; Bilginturan N; Movsesian MA; Klussmann E; Toka O; Bähring S
    Nat Genet; 2015 Jun; 47(6):647-53. PubMed ID: 25961942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and Brachydactyly Syndrome Associated With Vertebral Artery Malformation Caused by a PDE3A Missense Mutation.
    Fan P; Zhang D; Yang KQ; Zhang QY; Luo F; Lou Y; Liu YX; Zhang HM; Song L; Cai J; Wu HY; Zhou XL
    Am J Hypertens; 2020 Feb; 33(2):190-197. PubMed ID: 31549136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly.
    Toka O; Tank J; Schächterle C; Aydin A; Maass PG; Elitok S; Bartels-Klein E; Hollfinger I; Lindschau C; Mai K; Boschmann M; Rahn G; Movsesian MA; Müller T; Doescher A; Gnoth S; Mühl A; Toka HR; Wefeld-Neuenfeld Y; Utz W; Töpper A; Jordan J; Schulz-Menger J; Klussmann E; Bähring S; Luft FC
    Hypertension; 2015 Oct; 66(4):800-8. PubMed ID: 26283042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PDE3A mutation in familial hypertension and brachydactyly syndrome.
    Boda H; Uchida H; Takaiso N; Ouchi Y; Fujita N; Kuno A; Hata T; Nagatani A; Funamoto Y; Miyata M; Yoshikawa T; Kurahashi H; Inagaki H
    J Hum Genet; 2016 Aug; 61(8):701-3. PubMed ID: 27053290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE3A gene screening improves diagnostics for patients with Bilginturan syndrome (hypertension and brachydactyly syndrome).
    Renkema KY; Westermann JM; Nievelstein RAJ; Lo-A-Njoe SM; van der Zwaag B; Manshande ME; van Haelst MM
    Hypertens Res; 2018 Nov; 41(11):981-988. PubMed ID: 30209282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 3A and Arterial Hypertension.
    Ercu M; Markó L; Schächterle C; Tsvetkov D; Cui Y; Maghsodi S; Bartolomaeus TUP; Maass PG; Zühlke K; Gregersen N; Hübner N; Hodge R; Mühl A; Pohl B; Illas RM; Geelhaar A; Walter S; Napieczynska H; Schelenz S; Taube M; Heuser A; Anistan YM; Qadri F; Todiras M; Plehm R; Popova E; Langanki R; Eichhorst J; Lehmann M; Wiesner B; Russwurm M; Forslund SK; Kamer I; Müller DN; Gollasch M; Aydin A; Bähring S; Bader M; Luft FC; Klussmann E
    Circulation; 2020 Jul; 142(2):133-149. PubMed ID: 32524868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing identifies a de novo PDE3A variant causing autosomal dominant hypertension with brachydactyly type E syndrome: a case report.
    Li X; Li Z; Chen P; Wang Y; Wang DW; Wang DW
    BMC Med Genet; 2020 Jul; 21(1):144. PubMed ID: 32631253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
    Ercu M; Mücke MB; Pallien T; Markó L; Sholokh A; Schächterle C; Aydin A; Kidd A; Walter S; Esmati Y; McMurray BJ; Lato DF; Yumi Sunaga-Franze D; Dierks PH; Flores BIM; Walker-Gray R; Gong M; Merticariu C; Zühlke K; Russwurm M; Liu T; Batolomaeus TUP; Pautz S; Schelenz S; Taube M; Napieczynska H; Heuser A; Eichhorst J; Lehmann M; Miller DC; Diecke S; Qadri F; Popova E; Langanki R; Movsesian MA; Herberg FW; Forslund SK; Müller DN; Borodina T; Maass PG; Bähring S; Hübner N; Bader M; Klussmann E
    Circulation; 2022 Dec; 146(23):1758-1778. PubMed ID: 36259389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE3A variant associated with hypertension and brachydactyly syndrome in a patient with ischemic stroke caused by spontaneous intracranial artery dissection: A review of the clinical and molecular genetic features.
    Lee CG; Kang K; Yoon RG; Seo JY; Park JM
    Eur J Med Genet; 2020 Apr; 63(4):103781. PubMed ID: 31589936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension linked to PDE3A activation.
    Houslay M
    Nat Genet; 2015 Jun; 47(6):562-3. PubMed ID: 26018892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in Phosphodiesterase 3A (
    Ercu M; Walter S; Klussmann E
    Hypertension; 2023 Jun; 80(6):1171-1179. PubMed ID: 37035914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
    Liu H; Maurice DH
    Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Case| A handful of hypertension.
    van den Born BJ; Oskam LC; Zidane M; Schächterle C; Klussmann E; Bähring S; Luft FC
    Kidney Int; 2016 Oct; 90(4):911-3. PubMed ID: 27633875
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
    Kim YR; Yi M; Cho SA; Kim WY; Min J; Shin JG; Lee SJ
    Ann Hum Genet; 2021 Mar; 85(2):80-91. PubMed ID: 33249558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.
    Nagasaki K; Iida T; Sato H; Ogawa Y; Kikuchi T; Saitoh A; Ogata T; Fukami M
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1808-13. PubMed ID: 22723333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CHSY1 gene mutation underlies Temtamy preaxial brachydactyly syndrome in a Pakistani family.
    Sher G; Naeem M
    Eur J Med Genet; 2014 Jan; 57(1):21-4. PubMed ID: 24269551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Genetic Variation in
    Traylor M; Amin Al Olama A; Lyytikäinen LP; Marini S; Chung J; Malik R; Dichgans M; Kähönen M; Lehtimäki T; Anderson CD; Raitakari OT; Markus HS
    Hypertension; 2020 Feb; 75(2):365-371. PubMed ID: 31865795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
    Cheung PP; Yu L; Zhang H; Colman RW
    Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2.
    Lehmann K; Seemann P; Stricker S; Sammar M; Meyer B; Süring K; Majewski F; Tinschert S; Grzeschik KH; Müller D; Knaus P; Nürnberg P; Mundlos S
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12277-82. PubMed ID: 14523231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.